Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15877933rdf:typepubmed:Citationlld:pubmed
pubmed-article:15877933lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:15877933lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15877933lifeskim:mentionsumls-concept:C0016733lld:lifeskim
pubmed-article:15877933lifeskim:mentionsumls-concept:C0021493lld:lifeskim
pubmed-article:15877933lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:15877933lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:15877933lifeskim:mentionsumls-concept:C0813872lld:lifeskim
pubmed-article:15877933pubmed:issue4lld:pubmed
pubmed-article:15877933pubmed:dateCreated2005-10-5lld:pubmed
pubmed-article:15877933pubmed:abstractTextGSK-3beta is regarded as playing an important part in the pathogenesis of schizophrenia and the action of psychotomimetic agents. We observed phosphorylation of molecules associated with the GSK-3beta signalling pathway in the rat brain after MK-801 injection, which induces a schizophrenia-like state in humans. Ser9-GSK-3beta phosphorylation was increased after injection of 1 mg/kg MK-801 in the rat frontal cortex but not in the hippocampus or cerebellum. This increase peaked at 30 min and was maintained until 90 min after injection. The phosphorylation showed a dose-dependent increase up to 1 mg/kg MK-801, followed by a decrease at higher dosage. Furthermore, phosphorylation of Ser473-Akt and Ser133-CREB showed similar temporal, dose-dependent and regionally specific patterns with those of Ser9-GSK-3beta. However, phosphorylation of Dvl and Ser33-beta-catenin was not affected by MK-801. These results suggest that GSK-3beta phosphorylation by MK-801 may be associated with the Akt-GSK-3beta pathway rather than with the Wnt-Dvl-GSK3beta pathway.lld:pubmed
pubmed-article:15877933pubmed:languageenglld:pubmed
pubmed-article:15877933pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:citationSubsetIMlld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15877933pubmed:statusMEDLINElld:pubmed
pubmed-article:15877933pubmed:monthDeclld:pubmed
pubmed-article:15877933pubmed:issn1461-1457lld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:KimYong SikYSlld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:JuhnnYong-Sun...lld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:AhnYong MinYMlld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:YoonSe...lld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:KimSe HyunSHlld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:SeoMyoung...lld:pubmed
pubmed-article:15877933pubmed:authorpubmed-author:KimYeniYlld:pubmed
pubmed-article:15877933pubmed:issnTypePrintlld:pubmed
pubmed-article:15877933pubmed:volume8lld:pubmed
pubmed-article:15877933pubmed:ownerNLMlld:pubmed
pubmed-article:15877933pubmed:authorsCompleteYlld:pubmed
pubmed-article:15877933pubmed:pagination607-13lld:pubmed
pubmed-article:15877933pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:meshHeadingpubmed-meshheading:15877933...lld:pubmed
pubmed-article:15877933pubmed:year2005lld:pubmed
pubmed-article:15877933pubmed:articleTitleIncreased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection.lld:pubmed
pubmed-article:15877933pubmed:affiliationDepartment of Psychiatry and Behavioral Science, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-799, Korea.lld:pubmed
pubmed-article:15877933pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15877933pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15877933lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15877933lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15877933lld:pubmed